Cortesia Pharma Private Limited - Company Profile

It is a food and beverages private limited company based in Chennai, Tamil Nadu, India, established in 2017.
2017 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Cortesia Pharma Private Limited

Cortesia Pharma Private Limited, a active private limited company, was established on 02 August 2017 in Chennai, Tamil Nadu, India. Engaging in artificial fibres within the food and beverages sector, it holds CIN: U24304TN2017PTC120868. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹260.50 Cr and a paid-up capital of ₹253.08 Cr.

It upholds a compliant status. Its leadership includes Dattatraya Narayan Dhavalikar (Director), Godrej Baman Irani (Director). Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 13, Old No 5, A-3 Sai Niketan, Circular Road, United India Colony, Kodambakkam, Chennai, Tamil Nadu, 600024.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304TN2017PTC120868

  • Registration Number

    120868

  • Incorporation Date

    02 August 2017

  • Authorized Capital

    ₹260.50 Cr

  • Paid-Up Capital

    ₹253.08 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 260.50 Cr
  • Paid Up Capital ₹ 253.08 Cr
  • Company Age 8 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** -412.07%
  • Ebitda **** -579.36%
  • Net Worth -18.02%
  • Total Assets -16.39%
Company report

Cortesia Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cortesia Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cortesia Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Dattatraya Narayan Dhavalikar Director 02 Aug 2017 Current
Godrej Baman Irani Director 02 Aug 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cortesia Pharma.

Cortesia Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 412.07% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.02%.

Cortesia Pharma revenue growth over time
Cortesia Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -16.39%
*******
*******
*******
*******
Profit or Loss
*******
 -412.07%
*******
*******
*******
*******
Net Worth
*******
 -18.02%
*******
*******
*******
*******
EBITDA
*******
 -579.36%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cortesia Pharma?

Unlock access to Cortesia Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Cortesia Pharma?

Unlock and access historical data on people associated with Cortesia Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cortesia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cortesia Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cortesia Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Cortesia Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Cortesia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.

  • Director Appointment

    The activity Dattatraya Narayan Dhavalikar was appointed as a Director was appointed as a Director on 02 Aug 2017 & has been associated with this company since 8 years 6 months . was completed.

  • Director Appointment

    Godrej Baman Irani was appointed as a Director was appointed as a Director on 02 Aug 2017 & has been associated with this company since 8 years 6 months . was recorded as a recent event.

  • Company Incorporation

    The activity Cortesia Pharma Private Limited was registered on 02 Aug 2017 with Roc Chennai & aged 8 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cortesia Pharma Private Limited?

The CIN of Cortesia Pharma Private Limited is U24304TN2017PTC120868.

Where is Cortesia Pharma Private Limited headquartered?

Cortesia Pharma Private Limited is headquartered at 13, Old No 5, A-3 Sai Niketan, Circular Road, United India Colony, Kodambakkam, Chennai, Tamil Nadu, 600024.

When was Cortesia Pharma Private Limited incorporated?

Cortesia Pharma Private Limited was incorporated on 02 August 2017.

Who are the current directors of Cortesia Pharma Private Limited?

The current directors of Cortesia Pharma Private Limited are

What is the primary industry of Cortesia Pharma Private Limited?

The primary industry of Cortesia Pharma Private Limited is Food And Beverages.

Is Cortesia Pharma Private Limited a listed company?

Cortesia Pharma Private Limited is unlisted.

What is the capital structure of Cortesia Pharma Private Limited?

The authorized capital of Cortesia Pharma Private Limited is ₹260.50 Cr, and the paid-up capital is ₹253.08 Cr.

What is the compliance status of Cortesia Pharma Private Limited?

The compliance status of Cortesia Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available